a:3:{s:6:"_token";s:40:"mBgHBFTmONk9wd7RQw39BoQtM0kRy37jBy6xqLGc";s:9:"_previous";a:1:{s:3:"url";s:95:"https://www.pharmafocusasia.com/whitepapers/the-economic-viability-of-a-us-biosimilars-industry";}s:6:"_flash";a:2:{s:3:"old";a:0:{}s:3:"new";a:0:{}}}